Skip to content

To explore the efficacy and mechanism of mirror therapy on central facial paralysis

To explore the efficacy and mechanism of mirror therapy on central facial paralysis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055836
Enrollment
Unknown
Registered
2022-01-20
Start date
2022-01-20
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

control group:Conventional treatment

Sponsors

Shanghai Jing'an District Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with first cerebral infarction/cerebral hemorrhage confirmed by cranial computed tomography (CT) or magnetic resonance (MRI) examinations (diagnosed in accordance with the "Diagnosis of Various Major Cerebrovascular Diseases in China" formulated by the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association Key Points 2019 Consensus); 2. Good cognition, fluent in answering, and able to execute instructions; 3. Aged 18 to 80 years, primary school or above; 4. Voluntarily participate in this study and sign the informed consent; 5. Symptoms consistent with post-stroke symptoms Patients with central facial paralysis present with facial motor dysfunction below unilateral ocular cleft.

Exclusion criteria

Exclusion criteria: 1. Have a history of traumatic brain injury, epilepsy, alcohol or drug dependence, and other diseases that may affect brain function and structure; 2. Have a history of peripheral facial paralysis; 3. Have Alzheimer's disease, Parkinson's disease and other diseases that affect rehabilitation evaluation; 4. Patients with intolerance such as malignant tumor, bleeding tendency, active tuberculosis, severe cardiopulmonary insufficiency, etc.; 5. Patients with congenital facial paralysis; 6. Facial trauma and soft tissue contusion occurred within 2 weeks before the experiment; 7. Unilateral facial pain or tooth extraction or orthodontic treatment in the past week; 8. Patients who participated in other facial rehabilitation clinical trials or other central interventions (such as transcranial magnetic stimulation, transcranial direct current) during the same period.

Design outcomes

Primary

MeasureTime frame
The Sunnybrook facial grading system;

Secondary

MeasureTime frame
The House-Brackmann grading scale;The Facial Clinimetric Evaluation Scale;

Countries

China

Contacts

Public ContactJia Jie

Shanghai Jing'an District Central Hospital

shannonjj@126.com+86 13611722357

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026